Medical Specialty >> Pharmacy
Opioid Prescriptions Almost Twice as Likely for Rural vs. Urban Americans
2:00 PM CST.
By E.J. MundellHealthDay Reporter Read article
- Opioid Use in Pregnancy Tied to Severe Birth Defects
- When Your Medications Are the News
- More Americans Mixing Opioids With Sedatives
- 1 in 4 Antibiotic Prescriptions Isn’t Needed: Study
JOURNAL UPDATE
Antibiotics Often Inappropriately Prescribed for Bronchiolitis in ED
7:00 PM CST. In almost 70 percent of bronchiolitis cases, antibiotics prescribed with no concomitant infection- Ertugliflozin Seems Safe, Effective for Type 2 Diabetes Treatment
- Prevalence of Knee OA Lower With Menopausal Hormone Therapy
- Dermatologists’ Rx for Antibiotics Dropped From 2008 to 2016
MONTHLY JOURNAL SUMMARY
December 2018 Briefing - Pharmacy
January 02, 2019. The Monthly Journal Summary is a single article covering the most important journal articles published in the previous 30 days.
FEATURED ARTICLES
Rucaparib Maintenance Therapy Improves PFS in Platinum-sensitive Ovarian Cancer - The ARIEL3 Trial
Robert L. Coleman, MD.
Professor Robert L. Coleman M.D., FACOG, FACS discusses the implications of data from the Phase 3 ARIEL3 trial of the novel PARP inhibitor rucaparib as maintenance therapy in patients with platinum-sensitive ovarian cancer. Professor Coleman is the Vice Chair of Clinical Research in the Department of…
Investigational Topical Minocycline Gel for Acne Advances to Phase III Development
Ted Lain, MD.
Clinical trial investigator Dr. Ted Lain comments on the results of the OPAL study, a Phase 2b clinical trial which evaluated the efficacy of a novel topical gel formulation of the antibiotic minocycline (BPX-01) in reducing the number of inflammatory lesions in patients with moderate-to-severe inflammatory,…
Bevacizumab for breast cancer: FDA grants a stay of execution
Dr. Alberto De la Guerra.
The Food and Drug Administration has after repeated delays proposed removing metastatic breast cancer as an indication from the Avastin label. The proposal is being contested by Roche/Genentech, the drug’s maker. In this article we review the evidence for and against this decision.
MEDICAL FOCUS
DISCUSSION
RE: Investigational Topical Minocycline Gel for Acne Advances to Phase III Development
By MrRobinGreat articles. learnt a lot from it.
